Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: A favorable endogenous response

Clinical Biochemistry

Volumn 45, Issue 3, 2012, Pages 272-274

  Kumar, Ramesh ^a   Rastogi, Archana ^a   Maras, J S ^a   Sarin, Shiv Kumar ^a  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

Anti oxidant; Hyperbilirubinemia; NAFLD

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GILBERT DISEASE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIA; INSULIN BLOOD LEVEL; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BILIRUBIN; DEMOGRAPHY; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; HYPERBILIRUBINEMIA; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84856447307     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.11.017     Document Type: Article

References (10)

1. Seki S., Kitada T., Sakaguchi H. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol Res 2005, 33:132-134.
2. Stocker R., Glazer A.N., Ames B.N. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A 1987, 84:5918-5922.
3. Wu T.W., Fung K.P., Yang C.C. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci 1994, 54:477-481.
4. Wu T.W., Carey D., Wu J., Sugiyama H. The cytoprotective effects of bilirubin and biliverdin on rat hepatocytes and human erythrocytes and the impact of albumin. Biochem Cell Biol 1991, 69:828-834.
5. Lin J.P., O'Donnell C.J., Schwaiger J.P., Cupples L.A., Lingenhel A., Hunt S.C., et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006, 114:1476-1481.
6. Duseja A., Das A., Das R., Dhiman R.K., Chawla Y., Bhansali A. Unconjugated hyperbilirubinemia in nonalcoholic steatohepatitis-is it Gilbert's syndrome?. Trop Gastroenterol 2005, 26:123-125.
7. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
8. Lin Y.C., Chang P.F., Hu F.C., Chang M.H., Ni Y.H. Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. Pediatrics 2009, 124:e1221-e1227.
9. Arai T., Yoshikai Y., Kamiya J., Nagino M., Uesaka K., Yuasa N., et al. Bilirubin impairs bactericidal activity of neutrophils through an antioxidant mechanism in vitro. J Surg Res 2001, 96:107-113.
10. Shobana S., Naidu K.A. Antioxidant activity of selected Indian spices. Prostaglandins Leukot Essent Fatty Acids 2000, 62:107-110.